Project Details
Description
A Phase III Randomized Study of Neuroadiab in Combination with External Beam Radiation and Temozolomide Versus External beam Radiation and Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme
Status | Finished |
---|---|
Effective start/end date | 5/30/08 → 8/31/09 |
Funding
- BRADMER PHARMACEUTICALS, INC